🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

University of Electronic Science and Technology of China clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our China register with University of Electronic Science and Technology of China as lead sponsor. Synced 26 Sep 2026
25Current trials
23Recruiting now
2Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

University of Electronic Science and Technology of China is the lead sponsor of 25 current clinical trials in our China register. 23 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Oxytocin and Atosiban. The most-studied condition is Healthy.

ClinicalTrials.gov trials by status

  • Recruiting2392%
  • By invitation28%

Trials by phase

  • Not applicable1872%
  • Observational416%
  • Phase EARLY_PHASE128%
  • Phase 114%
01

Clinical trials sponsored by University of Electronic Science and Technology of China

25 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Neuromodulation and Attention Deficits in MDD
NCT07111169 · Major Depression Disorder, Cognitive Deficits, Selective Attention
Not applicable Recruiting 2024-01 China
Oxytocin's Effects on Emotional Processing and Its Acting Routes
NCT07425938 · ClinicalTrials.gov ↗ · Healthy Adult Male
Drug: Oxytocin
Not applicable Recruiting 2026-01 China
taVNS Effects on Fear Ratings in Naturalistic Context
NCT06975124 · ClinicalTrials.gov ↗ · Healthy Participants
Phase 1 Recruiting 2025-03 China
Continuous vs. Intermittent Rt-fMRI Neurofeedback Training of the Anterior Insula
NCT07389486 · ClinicalTrials.gov ↗ · Healthy
Not applicable Recruiting 2026-01 China
Oxytocin and Human Defensive Responses in a Dynamic Situation
NCT07162584 · ClinicalTrials.gov ↗ · Healthy
Drug: Oxytocin
Not applicable Recruiting 2025-09 China
Chatbot Intervention Effects on Social and Monetary Incentive Processing in Anhedonia
NCT07665242 · ClinicalTrials.gov ↗ · Healthy
Not applicable Recruiting 2026-06 China
Oxytocin's Effects on Real Time-fMRI Neurofeedback Training of Anterior Insula Activity
NCT07559656 · ClinicalTrials.gov ↗ · Healthy
Not applicable Recruiting 2026-04 China
Chatbot Intervention Effects on Emotional Arousal in Anhedonia
NCT07671131 · ClinicalTrials.gov ↗ · Healthy
Not applicable Recruiting 2026-06 China
The Power of Belief: Expectation-driven and Placebo Modulation of Empathic Pain
NCT07367672 · ClinicalTrials.gov ↗ · Healthy Participants
Not applicable Recruiting 2025-12 China
Social Feedback and Dysfunctional Risk Taking in NSSI Adolescents
NCT05981677 · ClinicalTrials.gov ↗ · Nonsuicidal Self Injury, Risk-Taking
Observational Recruiting 2023-12 China
Altered Neural Pain Empathic Reactivity in NSSI Adolescents
NCT05968313 · ClinicalTrials.gov ↗ · Nonsuicidal Self Injury, Pain Empathy
Observational Recruiting 2023-12 China
Real-time Neurofeedback Training of the Medial Prefrontal Cortex Based on Imagined Social Support
NCT07364084 · ClinicalTrials.gov ↗ · Healthy, Neurofeedback
Not applicable Recruiting 2026-01 China
The Effects of Oxytocin on Fairness Perception and Related Prosocial Behaviors
NCT07815496 · ClinicalTrials.gov ↗ · Healthy Adult Participants
Drug: Oxytocin
Not applicable Recruiting 2026-09 China
The Effect and Mechanism of taVNS in Modulating Human Social Attention
NCT07798349 · ClinicalTrials.gov ↗ · Healthy Adult, Role of Vagal Stimulation in Oxytocin Release, Role of Vagal Stimulation in Social Attention
Not applicable Recruiting 2026-08 China
Individual Differences in Cognitive Control Predict Real-time fMRI Neurofeedback Performance
NCT07211269 · ClinicalTrials.gov ↗ · Healthy
Not applicable Recruiting 2025-09 China
The Effect of Oral Oxytocin and Atosiban on Social Attention
NCT07093060 · ClinicalTrials.gov ↗ · Healhty
Phase EARLY_PHASE1 Recruiting 2025-06 China
Pain Relief From Dysmenorrhea Employing taVNS
NCT06912386 · ClinicalTrials.gov ↗ · Dysmenorrhea Primary
Not applicable Recruiting 2025-04 China
Emotion Regulation Dysfunctions in NSSI Adolescents in Naturalistic Contexts
NCT05907421 · ClinicalTrials.gov ↗ · Nonsuicidal Self Injury, Emotion Regulation
Observational Recruiting 2023-12 China
Chatbot Intervention Effects on Resting-State Brain Function in Anhedonia
NCT07665216 · ClinicalTrials.gov ↗ · Healthy
Not applicable Recruiting 2026-06 China
Impact of Emotional Reactivity on Dysfunctional Decision-Making in NSSI Adolescents
NCT05981612 · ClinicalTrials.gov ↗ · Nonsuicidal Self Injury, Prediction Errors
Observational Recruiting 2023-12 China
The Effect of Oral Oxytocin and Atosiban on Top-down Attention ( OTAtosiban )
NCT07140237 · ClinicalTrials.gov ↗ · Healthy Adult Male
Drug: Atosiban
Phase EARLY_PHASE1 Recruiting 2025-09 China
The Effects of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) on Anxiety Responses and Emotional Regulation
NCT07369908 · ClinicalTrials.gov ↗ · Healthy Male and Female Volunteers
Not applicable Recruiting 2025-10 China
Chatbot Intervention Effects on Belief Updating in Anhedonia
NCT07663019 · ClinicalTrials.gov ↗ · Healthy
Not applicable Recruiting 2026-06 China
The Effects and Mechanism of Parent Intervention for Autism Sprectrum Disorder
NCT07393893 · ClinicalTrials.gov ↗ · Autism Spectrum Disorder
Not applicable By invitation 2024-10 China
Neurofeedback Training of Anterior Insula Activity Based on Unidimensional vs. Multidimensional Interoceptive Regulation Strategies
NCT07416370 · ClinicalTrials.gov ↗ · Healthy
Not applicable By invitation 2026-02 China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in University of Electronic Science and Technology of China trials

2 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in University of Electronic Science and Technology of China trials

20 conditions
Healthy10Nonsuicidal Self Injury4Healthy Adult Male2Healthy Participants2Major Depression Disorder1Cognitive Deficits1Selective Attention1Autism Spectrum Disorder1Risk-Taking1Pain Empathy1Neurofeedback1Healthy Adult Participants1Healthy Adult1Role of Vagal Stimulation in Oxytocin Release1Role of Vagal Stimulation in Social Attention1Healhty1Dysmenorrhea Primary1Emotion Regulation1Prediction Errors1Healthy Male and Female Volunteers1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in China2523

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Healthy

SponsorTrials
Eli Lilly and Company15
Merck Sharp & Dohme14
Olly, PBC5
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences4
Boehringer Ingelheim3
dōTERRA International3
Qualia Life Sciences2
Clinical Nutrition Research Center, Illinois Institute of Technology2
Keymed Biosciences2
Shenyang Sunshine Pharmaceutical2

Sponsors with the most current trials registered for this condition.

06

Questions about University of Electronic Science and Technology of China trials

How many clinical trials does University of Electronic Science and Technology of China sponsor?

University of Electronic Science and Technology of China is the lead sponsor of 25 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are University of Electronic Science and Technology of China trials recruiting?

Yes. 23 of its 25 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is University of Electronic Science and Technology of China testing?

Its current trials name 2 drugs and biologicals as interventions. The most frequent are Oxytocin (4) and Atosiban (2). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.